Description
Overview
Tirzepatide is a synthetic dual agonist peptide designed to interact with glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptors. It is utilized in laboratory environments for research involving incretin-related signaling pathways and endocrine system interactions.
Product Specifications
- Compound: Tirzepatide (GLP-1 / GIP Receptor Agonist)
- Quantity: 10mg
- Form: Lyophilized powder
- Purity: Verified via third-party analytical testing
- Batch Documentation: Certificate of Analysis available
Analytical Verification
Each batch is supported by a Certificate of Analysis providing:
- Compound identity confirmation
- Purity data
- Analytical methodology
Documentation is available for batch-level verification and review.
Research Applications
Tirzepatide is studied in laboratory settings for its interaction with:
- GLP-1 and GIP receptor signaling pathways
- Incretin-related molecular systems
- Endocrine regulatory models
- Multi-receptor signaling mechanisms
All references to applications are provided for research context only.
Storage & Handling
- Store in a cool, dry environment
- Protect from light and heat
- Follow standard laboratory handling protocols
- Refer to product documentation for detailed storage guidance
Important Notice
This product is intended strictly for laboratory and research use only.
It is not intended for human or veterinary use, consumption, or application.
Reviews
There are no reviews yet.